Worldleish
An International Congress on Leishmania & Leishmaniasis
Why
?
Cutaneous, mucocutaneous and visceral
leishmaniases are seriou
s
diseases, which are vector-borne and wide-spread
in more than 90 countries, putting 350 million
population at risk. WHO estimates
an annual incidence of 2 million and a
total of 12 million current cases. The
causative agents are various species of
trypanosomatid protozoa in the genus of
Leishmania, which are excellent models
for aspects of laboratory studied in
cell/molecular biology, biochemistry,
immunology of host-parasite
interactions.
Who
?
Anyone interested in Leishmania and
leishmaniasis is welcome to participate,
including individuals of private and
public academic institutions, charitable
organizations, advocacy groups,
government officials/ representatives,
for-profit private sectors and their
friends/affiliates.
What ? Bring laboratory researchers and field workers from all disciplinary areas together for sharing new discoveries and exchange of new ideas. Provide opportunities of international collaboration, industrial participation, charitable donation and training of the next generation.